Enantiodivergent α-Amino C–H Fluoroalkylation Catalyzed by Engineered Cytochrome P450s
Abstract
The introduction of fluoroalkyl groups into organic compounds can significantly alter pharmacological characteristics. One enabling but underexplored approach for the installation of fluoroalkyl groups is selective C(sp^3)–H functionalization due to the ubiquity of C–H bonds in organic molecules. We have engineered heme enzymes that can insert fluoroalkyl carbene intermediates into α-amino C(sp3)–H bonds and enable enantiodivergent synthesis of fluoroalkyl-containing molecules. Using directed evolution, we engineered cytochrome P450 enzymes to catalyze this abiological reaction under mild conditions with total turnovers (TTN) up to 4070 and enantiomeric excess (ee) up to 99%. The iron-heme catalyst is fully genetically encoded and configurable by directed evolution so that just a few mutations to the enzyme completely inverted product enantioselectivity. These catalysts provide a powerful method for synthesis of chiral organofluorine molecules that is currently not possible with small-molecule catalysts.
Additional Information
© 2019 American Chemical Society. Received: April 22, 2019; Published: June 7, 2019. This work was supported by the National Science Foundation (NSF), Division of Molecular and Cellular Biosciences (grant MCB-1513007). X.H. is supported by an NIH pathway to independence award (Grant K99GM129419). R.K.Z. acknowledges support from the NSF Graduate Research Fellowship (grant DGE-1144469) and the Donna and Benjamin M. Rosen Bioengineering Center. We thank S. Brinkmann-Chen, K. Chen, Z. Jia, S. B. J. Kan, A. M. Knight, L. J. Schaus, D. J. Wackelin, E. J. Watkins, and Y. Yang for helpful discussion and comments. We also thank N. Torian, M. Shahoholi and the Caltech Mass Spectrometry Laboratory, and L. M. Henling and the Caltech X-ray Crystallography Facility for analytical support. Author Contributions: J.Z. and X.H. contributed equally. The authors declare no competing financial interest.Attached Files
Accepted Version - nihms-1038275.pdf
Supplemental Material - ja9b04344_si_001.pdf
Supplemental Material - ja9b04344_si_002.cif
Supplemental Material - ja9b04344_si_003.cif
Files
Additional details
- PMCID
- PMC6666315
- Eprint ID
- 96204
- DOI
- 10.1021/jacs.9b04344
- Resolver ID
- CaltechAUTHORS:20190607-130827085
- NSF
- MCB-1513007
- NIH
- K99GM129419
- NSF Graduate Research Fellowship
- DGE-1144469
- Donna and Benjamin M. Rosen Bioengineering Center
- Created
-
2019-06-07Created from EPrint's datestamp field
- Updated
-
2022-02-15Created from EPrint's last_modified field
- Caltech groups
- Rosen Bioengineering Center